CN101829248A - Traditional Chinese medicine for treating goiter - Google Patents
Traditional Chinese medicine for treating goiter Download PDFInfo
- Publication number
- CN101829248A CN101829248A CN201010183100A CN201010183100A CN101829248A CN 101829248 A CN101829248 A CN 101829248A CN 201010183100 A CN201010183100 A CN 201010183100A CN 201010183100 A CN201010183100 A CN 201010183100A CN 101829248 A CN101829248 A CN 101829248A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- goiter
- treating
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 206010018498 Goitre Diseases 0.000 title abstract description 13
- 201000003872 goiter Diseases 0.000 title abstract description 12
- 241000006375 Calceolaria Species 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 241001530126 Scrophularia Species 0.000 claims abstract description 6
- 238000011282 treatment Methods 0.000 claims description 18
- 244000025254 Cannabis sativa Species 0.000 claims description 11
- 241000195474 Sargassum Species 0.000 claims description 11
- 241001523579 Ostrea Species 0.000 claims description 6
- 244000179560 Prunella vulgaris Species 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 208000026435 phlegm Diseases 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract 2
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 244000299788 selfheal Species 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 241001529739 Prunella <angiosperm> Species 0.000 description 7
- 201000007227 lymph node tuberculosis Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010067997 Iodine deficiency Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 235000006479 iodine deficiency Nutrition 0.000 description 2
- 229950008325 levothyroxine Drugs 0.000 description 2
- 229960003918 levothyroxine sodium Drugs 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000008496 endemic goiter Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000013076 thyroid tumor Diseases 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating goiter, which is prepared from the following raw materials in parts by weight: 20-40 parts of calceolaria, 20-40 parts of radix scrophularia, 30-50 parts of kelp, 50-70 parts of selfheal, 50-70 parts of varech and 100-120 parts of oyster. The invention belongs to the Chinese medicinal herb, and has functions of resolving hard lump, promoting blood circulation by removing blood stasis, soothing liver and regulating qi and resolving phlegm, thereby radically regulating and treating the whole body, treating the goiter with more pertinence and achieving the purpose of recovering health.
Description
Technical field the present invention relates to a kind of treatment Chinese medicine for oral administration strumous, belongs to pure Chinese herbal medicine.
Background technology goiter is a kind of endemic diseases that causes because of the endemicity iodine deficiency.Cardinal symptom is a thyromegaly, is commonly called as " big thick neck " " thick neck root " " wart bag ", the multithread row in the mountain area, upper level, the place, Plain is dispersed in generation.In recent years also found endemic goiter in coastal high iodine area, this disease belongs to worldwide disease.Pathogenic factor mainly contains: in the popular district water and soil iodine deficiency or too much, the increase of iodine requirement, goitrogen, drink phreatic water, water source by germ contamination, the congenital thyroxin synzyme of familial defective etc.Existing therapy is to adopt levothyroxine and operative treatment mostly, and primary disease treatment difficulty especially to the gerontal patient, uses the levothyroxine malpractice then can bring out and increase the weight of coronary heart disease.
Summary of the invention technical problem to be solved by this invention is: a kind of treatment Chinese medicine strumous and preparation method thereof is provided.Treating both the principal and secondary aspects of a disease is accomplished in pointed an amount of medication, eliminates disease, to reach therapeutic purposes.
Technical scheme of the present invention is as follows:
A kind of treatment Chinese medicine strumous is characterized in that: made by the following weight proportion raw material: Calceolaria (Pollen Typhae grass) 20-40 part, Radix Scrophulariae 20-40 part, Thallus Laminariae (Thallus Eckloniae) 30-50 part, Spica Prunellae 50-70 part, Sargassum 50-70 part, Concha Ostreae 100-120 part.
Preferred composition of raw materials is as follows: 30 parts of Calceolarias (Pollen Typhae grass), 30 parts of Radix Scrophulariaes, 40 parts of Thallus Laminariae (Thallus Eckloniae)s, 60 parts of Spica Prunellaes, 60 parts of Sargassums, 110 parts of Concha Ostreaes.
The main Chinese herbal medicine of prescription of the present invention is according to traditional medicine and modern medicine analysis, and the property of medicine and pharmacological action are as follows:
Calceolaria (Pollen Typhae grass): sweet, flat.Return liver, pericardium channel.Hemostasis with astringents, the promoting the circulation of blood blood stasis dispelling.
Radix Scrophulariae: be slightly cold; Sweet, bitter, salty; Return lung, stomach, kidney channel.The removing heat from blood YIN nourishing, eliminating fire and detoxication.Be used for consumption of YIN caused by febrile disease, conjunctival congestion, pharyngalgia, scrofula, diphtheria, carbuncle sore tumefacting virus.
Thallus Laminariae (Thallus Eckloniae): cold; Salty; Return liver, stomach, kidney channel.Hard masses softening and resolving, expectorant, diuretic.Be used for goiter, scrofula, the phlegm retention edema.
Spica Prunellae: cold; Bitter, hot; Return liver, gallbladder meridian.Relieve inflammation or internal heat, make eye bright, eliminating stagnation, detumescence.Be used for conjunctival congestion and swelling pain, order pearl nyctalgia, it is dizzy to have a headache, scrofula, goiter swells and ache; Thyromegaly, tuberculous lymphadenitis, hypertension.
Sargassum: cold; Salty; Return liver, kidney channel.Hard masses softening and resolving, expectorant, diuretic.Be used for goiter, scrofula, phlegm retention edema.
Concha Ostreae: be slightly cold; Salty; Return liver, gallbladder, kidney channel.Suppressing the hyperactive liver and subsiding YANG, hard masses softening and resolving is restrained astringent or styptic treatment for spontaneous sweating.Be used for the palpitation with fear insomnia, vertigo and tinnitus, scrofula sucutaneous nodule ， WEIJIA mass in the abdomen.
The present invention is Chinese herbal medicine sheerly, and the effect of hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, dispersing the stagnated live-QI to relieve the stagnation of QI, activating QI to eliminate phlegm is arranged, can fundamentally whole conditioning and treating, treat goiter more targetedly, and reach restorative purpose.From in January, 2 to 2010 in 2007, with medicine of the present invention in mountain, Yantai hospitalize goiter 50 examples, and with use levothyroxine sodium treatment treatment goiter 30 examples.The result shows medicine group obvious effective rate 70% of the present invention, total effective rate 92%; Thyroxine therapy group obvious effective rate 46.7%, total effective rate 65.1%.
Diagnostic criteria is with reference to State Administration of Traditional Chinese Medicine " disease of tcm diagnosis criterion of therapeutical effect ".
Treatment group 1: medicine of the present invention, 1 bag/sky, 9 days is 1 course of treatment.
Matched group 2: levothyroxine sodium (the Jiangsu Australia medical logistics company limited in ocean), 2 slices/time, every day 2 times, 9 days is 1 course of treatment.
Every group is all carried out efficacy evaluation in treatment after 9 days.Difference (P＜0.05) that there are no significant aspect case source, sex age, the course of disease, cardinal symptom before two groups of treatments has comparability.But check symptom before and after the clear view treatment by CT and MRI, comprise thyroid tumor size, form and with trachea, esophagus, blood vessel even neural position relationship change, and observe and have or not bad reflection.
Medicine of the present invention respectively and contrast organize between relatively, significant difference is arranged.Medicine of the present invention is being eliminated clinical symptoms, and toxic and side effects is little, and cost is low, and aspects such as treating both the principal and secondary aspects of a disease all are better than other medicines.
Two groups of therapeutic outcomes see the following form:
| Group | The example number | Cure | Produce effects | Effectively | Invalid | Cure rate, total effective rate |
| The treatment group | ??50 | ??35 | ??6 | ??5 | ??4 | ??70％???92％ |
| Matched group | ??30 | ??14 | ??6 | ??3 | ??7 | ??46.7％?77％ |
The specific embodiment is in order to understand better and to implement, and embodiment further specifies the present invention below in conjunction with preparation.
Embodiment one:
The weight proportion of raw material is as follows: 20 parts of Calceolarias (Pollen Typhae grass), 20 parts of Radix Scrophulariaes, 30 parts of Thallus Laminariae (Thallus Eckloniae)s, 50 parts of Spica Prunellaes, 50 parts of Sargassums, 100 parts of Concha Ostreaes.
Preparation process is as follows:
(1) get 20 parts of Calceolarias (Pollen Typhae grass), Radix Scrophulariae, 30 parts of Thallus Laminariae (Thallus Eckloniae)s, 50 parts of Spica Prunellaes, Sargassum, 100 parts of Concha Ostreae mixed powders are broken into 100 purpose granules.
(2) (1) gained mixture microwave was baked 2-3 minute, be cooled to room temperature.
(3) be distributed into parcel, every bag 30 grams are standby.
Using method: place the vessel decocting oral after 15 minutes, once a day, each bag.
Embodiment two:
The weight proportion of raw material is as follows: 30 parts of Calceolarias (Pollen Typhae grass), 30 parts of Radix Scrophulariaes, 40 parts of Thallus Laminariae (Thallus Eckloniae)s, 60 parts of Spica Prunellaes, 60 parts of Sargassums, 110 parts of Concha Ostreaes.
Preparation process is as follows:
(1) gets 30 parts of Calceolarias (Pollen Typhae grass), Radix Scrophulariae, 40 parts of Thallus Laminariae (Thallus Eckloniae)s, 60 parts of Spica Prunellaes, Sargassum, 110 parts of Concha Ostreaes.
(2) (1) gained mixture microwave was baked 2-3 minute, be cooled to room temperature.
(3) be distributed into parcel, every bag 30 grams are standby.
Using method: place the vessel decocting oral after 15 minutes, once a day, each bag.
Embodiment three:
The weight proportion of raw material is as follows: 40 parts of Calceolarias (Pollen Typhae grass), 40 parts of Radix Scrophulariaes, 50 parts of Thallus Laminariae (Thallus Eckloniae)s, 70 parts of Spica Prunellaes, 70 parts of Sargassums, 120 parts of Concha Ostreaes.
Preparation process is as follows:
(1) get 40 parts of Calceolarias (Pollen Typhae grass), Radix Scrophulariae, 50 parts of Thallus Laminariae (Thallus Eckloniae)s, 70 parts of Spica Prunellaes, Sargassum, 120 parts of mixed powders of Concha Ostreae are broken into 100 purpose granules.
(2) (1) gained mixture microwave was baked 2-3 minute, be cooled to room temperature.
(3) be distributed into parcel, every bag 30 grams are standby.
Using method: place the vessel decocting oral after 15 minutes, once a day, each bag.
Claims (2)
1. a treatment Chinese medicine strumous is characterized in that: made by the following weight proportion raw material: Calceolaria (Pollen Typhae grass) 20-40 part, Radix Scrophulariae 20-40 part, Thallus Laminariae (Thallus Eckloniae) 30-50 part, Spica Prunellae 50-70 part, Sargassum 50-70 part, Concha Ostreae 100-120 part.
2. a kind of treatment as claimed in claim 1 Chinese medicine strumous is characterized in that: made by the following weight proportion raw material: 30 parts of Calceolarias (Pollen Typhae grass), 30 parts of Radix Scrophulariaes, 40 parts of Thallus Laminariae (Thallus Eckloniae)s, 60 parts of Spica Prunellaes, 60 parts of Sargassums, 110 parts of Concha Ostreaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101831004A CN101829248B (en) | 2010-05-18 | 2010-05-18 | Traditional Chinese medicine for treating goiter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101831004A CN101829248B (en) | 2010-05-18 | 2010-05-18 | Traditional Chinese medicine for treating goiter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101829248A true CN101829248A (en) | 2010-09-15 |
| CN101829248B CN101829248B (en) | 2013-10-16 |
Family
ID=42713570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101831004A Expired - Fee Related CN101829248B (en) | 2010-05-18 | 2010-05-18 | Traditional Chinese medicine for treating goiter |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101829248B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362633A (en) * | 2014-08-21 | 2016-03-02 | 李新民 | Formula for treating hyperthyroidism |
| CN106075008A (en) * | 2016-06-15 | 2016-11-09 | 山东仙河药业有限公司 | A kind of Spica Prunellae granule and preparation method thereof |
| CN112107667A (en) * | 2020-10-20 | 2020-12-22 | 辽宁中医药大学 | Traditional Chinese medicine compound preparation for treating Graves disease |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161858A (en) * | 1997-03-28 | 1997-10-15 | 封永军 | Chinese herbal medicine for treating thyreoidism |
| CN1277033A (en) * | 2000-05-22 | 2000-12-20 | 杨友文 | Medicine for treating benign goiter |
| CN101129979A (en) * | 2007-08-23 | 2008-02-27 | 徐恒雁 | Orally taken traditional Chinese medicine composition for treating hyperthyroidism |
| CN101152400A (en) * | 2007-09-15 | 2008-04-02 | 尹克华 | Traditional Chinese medicine for treating simple goiter |
| CN101195022A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for curing tumor |
-
2010
- 2010-05-18 CN CN2010101831004A patent/CN101829248B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161858A (en) * | 1997-03-28 | 1997-10-15 | 封永军 | Chinese herbal medicine for treating thyreoidism |
| CN1277033A (en) * | 2000-05-22 | 2000-12-20 | 杨友文 | Medicine for treating benign goiter |
| CN101129979A (en) * | 2007-08-23 | 2008-02-27 | 徐恒雁 | Orally taken traditional Chinese medicine composition for treating hyperthyroidism |
| CN101152400A (en) * | 2007-09-15 | 2008-04-02 | 尹克华 | Traditional Chinese medicine for treating simple goiter |
| CN101195022A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for curing tumor |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362633A (en) * | 2014-08-21 | 2016-03-02 | 李新民 | Formula for treating hyperthyroidism |
| CN106075008A (en) * | 2016-06-15 | 2016-11-09 | 山东仙河药业有限公司 | A kind of Spica Prunellae granule and preparation method thereof |
| CN106075008B (en) * | 2016-06-15 | 2020-02-07 | 山东仙河药业有限公司 | Selfheal granules and preparation method thereof |
| CN112107667A (en) * | 2020-10-20 | 2020-12-22 | 辽宁中医药大学 | Traditional Chinese medicine compound preparation for treating Graves disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101829248B (en) | 2013-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103920106A (en) | Traditional Chinese medicinal composition for treating bronchitis and bronchial asthma | |
| CN101327297A (en) | Chinese medicine composition for treating insomnia | |
| CN101829248B (en) | Traditional Chinese medicine for treating goiter | |
| CN100411668C (en) | A cancer-treating medicine | |
| CN102579807B (en) | Chinese medicine composition for treating dental ulcer | |
| CN102552804B (en) | Chinese medicine composite for curing verruca plantaris | |
| CN106963921A (en) | It is a kind of to treat external medicine composition of the proliferation of mammary gland and preparation method thereof | |
| CN104721489A (en) | Chinese patent medicine for treating Parkinson disease and preparation method thereof | |
| CN104547736A (en) | Medicine for treating goiter | |
| CN103893432B (en) | It is a kind of to treat fracture, pharmaceutical composition of soft tissue injury and preparation method thereof | |
| CN103272195B (en) | Traditional Chinese medicine paste for treating pain | |
| CN100360161C (en) | Chinese medicine for treating diabets and nephritis | |
| CN102885946A (en) | Chinese medicament for treating cough and asthma | |
| CN104383175A (en) | Medicine for treating chronic osteomyelitis and preparation method of medicine | |
| CN104491268A (en) | Traditional Chinese medicine capsule for treating lymphoma and preparation method thereof | |
| CN103933389B (en) | Traditional Chinese medicine composition for treating ovarian cyst | |
| CN102293994A (en) | Medicine for treating thyroiditis and preparation method | |
| CN102335407A (en) | Chinese medicinal composition for treating acute gastric dilatation of horses | |
| CN102166340B (en) | Chinese medicine composition for treating sthenia heat edema | |
| CN105434533A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN102247584A (en) | Traditional Chinese medicine for treating kidney-deficiency vertigo and preparation method thereof | |
| CN100391515C (en) | Chinese patent medicine for treating primary lung cancer | |
| CN106214941A (en) | A kind of can effective Chinese medicine composition treating diabetes and preparation method thereof | |
| CN105288344A (en) | Traditional Chinese medicinal composition for treating liver and gall calculi, and application thereof | |
| CN104666840A (en) | Medicine for treating hyperthyroidism and preparation method of medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 265400 Zhaoyuan, Shandong, spa Road, No. 111, No. Applicant after: Gong Zhaorong Address before: 264003 Shandong Province, Yantai city Laishan District Yingchun Street No. 129-1 Applicant before: Gong Zhaorong |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: QIDONG TIANFEN ELECTRIC TOOL TECHNOLOGY INNOVATION Free format text: FORMER OWNER: GONG ZHAORONG Effective date: 20141210 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 265400 YANTAI, SHANDONG PROVINCE TO: 226241 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141210 Address after: Qidong City, Jiangsu province 226241 Nantong lvsigang Tianfen electric tools trade city comprehensive building Patentee after: Qidong Tianfen Electric Tool Technology Innovation Center Address before: 265400 Zhaoyuan, Shandong, spa Road, No. 111, No. Patentee before: Gong Zhaorong |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181024 Address after: 344000 70 building, A10 building, business incubation base, Fuzhou hi tech Industrial Development Zone, Fuzhou, Jiangxi, China. 2 Patentee after: Jiangxi Bofen Medical Devices Co.,Ltd. Address before: 226241 Jiangsu, Nantong, Qidong City, Lv Si Gang Town, Tian Fen electric tools business city complex building Patentee before: Qidong Tianfen Electric Tool Technology Innovation Center |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131016 |